Sign Up
Stories
Amyloid PET Imaging Biomarker Collaboration
Share
Advancements in Alzheimer's and Parkinso...
Alzheimer's Market Growth Projections
Alzheon's Patent Victory and Clinical Pr...
Breakthrough Alzheimer's Blood Test Stud...
Breakthrough Alzheimer's Detection Test
Breakthrough Alzheimer’s Detection Test
Overview
API
Meilleur Technologies, Inc. collaborates with the Young Blood Institute (YBI) to employ the investigational imaging agent [F-18]NAV-4694 to detect amyloid plaque in the brain, aiming to prevent Alzheimer's disease. The collaboration focuses on early detection and clearance of Amyloid βeta using Therapeutic Plasma Exchange (TPE). Meilleur Technologies aims to expand the availability of this novel investigational imaging agent to the broader scientific community.
Ask a question
How could this collaboration impact the field of neuroscience and potential treatments for Alzheimer's disease?
How might the use of [F-18]NAV-4694 impact the early detection and prevention of Alzheimer's disease?
What are the potential implications of expanding the availability of [F-18]NAV-4694 to the broader scientific community?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Sep 2023
Oct 2023
Nov 2023
Coverage